Tatva Chintan Pharma Chem Ltd

Stage 2 · Advancing · week 12Setup 7.9 ★★ GoodSolid +1.0

As of 16 Oct 2026, Tatva Chintan Pharma Chem is in Stage 2 — advancing, the uptrend phase, in week 12 (since 28 Jul 2026). It closed at ₹1,944, 2.4% below its 52-week high and above its 200-day average, which is rising. In Materials, 33.6% of stocks are in Stage 2.

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. More about the company

₹1,944
+0.17% today
₹4,547 Cr · Small cap
Market Neutral — FadingMaterials 33.6% in Stage 2-2.9 pts / 20dSpecialty Chemicals 43.8%-3.4 pts

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

7.9 ★★ Good

Momentum

Steady

Edge

Solid +1.0

Setup-score rank among Stage 2 peers: #2 of 39 in Specialty Chemicals · #9 of 153 in Materials

Is TATVA early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-2.4%
₹1,048 lo₹1,991.2 hi
2.4% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 12
1w13w26w
Week 12 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
40.1%
200 DMA: ₹1,387.6 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
1.18x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑
MA20 trending up · +6.9% vs MA50 +5.4%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+18.0%
3M
+36.1%
6M
+51.4%
YTD
+41.8%
1Y
+83.8%
Sector
Materials
↓ Peaking
Stage 2%
33.6%
20d Δ
-2.9pp
1M return
-1.6%
3M return
-2.6%
Sector Stage-2 % · last 20 days
This stock ranks #23 of 151 Stage 2 stocks in Materials by RS. Leading the sector.
Industry
Specialty Chemicals
↓ Peaking
Stage 2%
43.8%
20d Δ
-3.4pp
1M return
+0.5%
3M return
+9.2%
Industry Stage-2 % · last 20 days
Ranks #5 of 38 Stage 2 stocks in this industry. Top tier.
Stage Cycle Timeline2023-07-20 → 2026-10-16
S4 18w
S4 67w
S2 30w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 6w → S4 18w → S1 4w → S4 67w → S1 6w → S2 30w → S3 10w → S4 4w → S1 12w → S2 12w current
Total tracked: 169 weeks across 10 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-16
Pullback Hunter
Latest: 2026-10-08
60 appearances in last 60 days. First seen: 2026-07-29.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-16S2
Wk 12 · Vol 1.18x
2026-10-15S2
Wk 12 · Vol 1.08x
2026-10-14S2
Wk 11 · Vol 1.54x
2026-10-13S2
Wk 11 · Vol 0.88x
2026-10-12S2
Wk 11 · Vol 0.99x
2026-10-09S2
Wk 11 · Vol 1.05x
2026-10-08S2
Wk 11 · Vol 1.88x
2026-10-07S2
Wk 10 · Vol 3.76x
2026-10-06S2
Wk 10 · Vol 1.77x
2026-10-05S2
Wk 10 · Vol 0.68x
2026-10-01S2
Wk 10 · Vol 0.76x
2026-09-30S2
Wk 10 · Vol 0.47x
Sector Peers — Stage 2All →
OCCLLTD
wk 17 · -16.3% from hi
9.0
MUKANDLTD
wk 21 · -7.5% from hi
8.9
SUNFLAG
wk 3 · -9.3% from hi
8.8
CUBEXTUB
wk 2 · 0.0% from hi
8.7
NRL
wk 17 · 0.0% from hi
8.6
Moving averages & range
50 DMA
₹1,726.9
200 DMA
₹1,387.6
52W High
₹1,991.2
52W Low
₹1,048
5D Low
₹1,841.3
Resistance levels (recent highs)
20d High
₹1,991.2
60d High
₹1,991.2
120d High
₹1,991.2
250d High
₹1,991.2
Next resistance
+2.4%
to 20d High
Ask the Market AI about TATVAAsk →
P/E (TTM)
63.9
Forward 29.9
Earnings Growth (YoY)
+907.5%
Revenue +24.4%
ROE
+5.5%
Profit margin +8.3%
Dividend Yield
0.09%
P/B 3.4
About this companyMaterials· Specialty Chemicals

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.